Nomination for an early re-entry resubmission - what exactly does it mean?

12 September 2022 - We compare and contrast the submissions nominated by the PBAC in March for an early re-entry ...

Read more →

Hope for change after PHARMAC independent review

2 June 2022 - A woman who had her bowel removed while she waited for drugs that would probably have ...

Read more →

Government response to independent PHARMAC review

1 June 2022 - The Government has released its response to the recommendations of the final report of the independent ...

Read more →

Application accompanying data collection in the case of market access for several active substances in a class: IQWiG presents a concept

27 May 2022 - The institute recommends platform studies under a master's protocol. ...

Read more →

Calls for Health Minister to release final report from PHARMAC review

11 May 2022 - Health Minister Andrew Little is facing calls to release the final report from a review of ...

Read more →

UK’s NICE to launch sweeping changes to drug assessments to be faster, more agile

19 January 2022 - The health technology assessment body has been under pressure from drugmakers and patient groups for years to ...

Read more →

NICE launches ambitious strategy to provide quicker access to new treatments and innovations

19 April 2021 - NICE will transform key elements of its approach to ensure efficiency and speed while maintaining robust, trusted ...

Read more →

NICE methods and process review aims to create fertile ground for innovation

29 March 2021 - The way NICE reviews new medicines is about to go through its biggest change in years – ...

Read more →

New procedures for CADTH drug reimbursement reviews

30 September 2020 - CADTH initiated stakeholder consultations in June 2020 on proposals to align the procedure for its drug ...

Read more →

Mallinckrodt and Terumo BCT announce positive recommendations for public funding of Uvadex (methoxsalen) for ECP administration with the Therakos CE

13 July 2020 - In a rare dual-review process, two independent advisory committees to the Australian Minister for Health recommend reimbursement ...

Read more →

Proposal to modify PHARMAC’s approach to competitive procurement

10 July 2020 - PHARMAC is proposing to standardise the way that it contracts for pharmaceuticals as a result of ...

Read more →

Consultation on CADTH’s drug reimbursement review procedures

25 June 2020 - CADTH is inviting stakeholder feedback on a revised procedure for its drug reimbursement review processes (i.e., pan-Canadian ...

Read more →

Procedure Guidance for standardised redactions to PBAC Public Summary Documents

30 April 2020 - The PBAC has indicated its preference for greater transparency to be introduced in PSDs through a ...

Read more →

Revised procedure for the sponsor review of initial CADTH pCODR reports

4 March 2020 - Initial CADTH pCODR reports will now be issued to the sponsor four business days before the target ...

Read more →

Alignment of terminology

9 January 2020 - CADTH is aligning the terminology in the single drug review processes as follows: ...

Read more →